Beaphar Worming Cream, 25% W/W, Oral Suspension
Revised: 01 February 2010
Summary of Product Characteristics
1. Name of the Veterinary Medicinal Product
Beaphar Worming Cream, 25% w/w, oral suspension
2. Qualitative and Quantitative Composition
Active substance % w/w
Piperazine Citrate 25.00
Excipients % w/w
Titanium Dioxide 3.00
Methyl Parahydroxybenzoate 0.15
For full list of excipients, see section 6.1
3. Pharmaceutical form
A soft, white to off-white cream.
4. Clinical Particulars
4.1 Target species
Dogs and cats.
4.2 Indications for use, specifying the target species
For the treatment of roundworms (Ascarids) in dogs and cats.
4.4 Special warnings for each target species
Consult a veterinary surgeon before treating pregnant animals or those with a history of epilepsy or severe renal disfunction.
4.5 Special precautions for use
i. Special precautions for use in animals
Do not exceed the recommended dosage.
ii. Special precautions to be taken by the person administering the medicinal product to animals
Following accidental skin or eye contact, wash the affected area with plenty of water. If irritation persists, seek medical advice.
Following accidental ingestion, drink plenty of water and seek medical attention.
Wash hands and exposed skin after use.
4.6 Adverse reactions (frequency and seriousness)
Overdosage. See Section 4.10.
4.7 Use during pregnancy, lactation or lay
Nursing female animals should be treated two weeks after giving birth and every two weeks until weaning.
4.8 Interaction with other medicinal products and other forms of interaction
4.9 Amounts to be administered and administration route
The cream may be administered either by dabbing the required amount (see table below) onto the nose or mouth, from where the animal will lick it off, or given on a biscuit, or added to a small amount of the animal’s daily meal (give the remainder afterwards). If your household has more than one dog or cat, feed them separately to ensure that each receives the correct dosage.
Each graduation of the syringe will dispense the correct volume of Worming Cream for 1.0 kg bodyweight, e.g.
Animal Weight Number of graduations
1.0 (2.2) 1
2.0 (4.4) 2
3.0 (6.6) 3
4.0 (8.8) 4
5.0 (11.0) 5
10.0 (22.0) 10
The syringe is marked with guidelines for each 1 kg bodyweight dose.
To administer the correct volume, depress plunger the required number of graduations for the weight of the animal.
Puppies and kittens should be treated for roundworms at 2 weeks of age.
They should be re-treated at 4, 6, 8, 10 and 12 weeks of age, and thereafter at 2 to 3 monthly intervals.
Adult dogs and cats should be treated at 3 monthly intervals.
Female animals should be wormed at the same time and as frequently as their puppies or kittens until weaning.
4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary
Symptoms: Vomiting and diarrhoea, depression, ataxia and muscle weakness, and fits.
Emergency Procedures: Consult a veterinary surgeon. Treat symptomatically and supportively. Keep animal warm and calm. Symptoms reverse in 24-48 hours.
4.11 Withdrawal period(s)
5. Pharmacological properties
5.1 Pharmacodynamic properties
Worms are killed in the gastro-intestinal tract and may be expelled in the faeces or digested in their passage through the tract.
5.2 Pharmacokinetic particulars
6. Pharmaceutical particulars
6.1 List of excipients
Silica Colloidal Anhydrous
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 18 months.
6.4 Special precautions for storage
Do not store above 25°C.
6.5 Nature and composition of immediate packaging
Pack size: 18 g
Container: Graduated syringe with high density polyethylene barrel and low density polyethylene piston.
Closure: Low density polyethylene cap (push fit).
Secondary pack: One carton containing one syringe.
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Marketing authorisation holder
Beaphar UK Ltd.
8. Marketing authorisation number
9. Date of first authorisation/renewal of the authorisation
Date of first authorisation: 21 September 1994
10. Date of revision of the text